nodes	percent_of_prediction	percent_of_DWPC	metapath
Verteporfin—Lacrimal structural disorder—Mesalazine—Crohn's disease	0.052	0.052	CcSEcCtD
Verteporfin—Prostatic disorder—Mesalazine—Crohn's disease	0.036	0.036	CcSEcCtD
Verteporfin—Lacrimal disorder—Mesalazine—Crohn's disease	0.0342	0.0342	CcSEcCtD
Verteporfin—Blister—Mesalazine—Crohn's disease	0.0212	0.0212	CcSEcCtD
Verteporfin—Albuminuria—Mesalazine—Crohn's disease	0.0205	0.0205	CcSEcCtD
Verteporfin—Scotoma—Mesalazine—Crohn's disease	0.0201	0.0201	CcSEcCtD
Verteporfin—Hyperaesthesia—Mesalazine—Crohn's disease	0.0195	0.0195	CcSEcCtD
Verteporfin—Arthropathy—Mesalazine—Crohn's disease	0.0168	0.0168	CcSEcCtD
Verteporfin—Musculoskeletal pain—Mesalazine—Crohn's disease	0.0155	0.0155	CcSEcCtD
Verteporfin—Dry eye—Mesalazine—Crohn's disease	0.0141	0.0141	CcSEcCtD
Verteporfin—Immune system disorder—Mercaptopurine—Crohn's disease	0.0128	0.0128	CcSEcCtD
Verteporfin—Photosensitivity—Mesalazine—Crohn's disease	0.0126	0.0126	CcSEcCtD
Verteporfin—Eczema—Mesalazine—Crohn's disease	0.0123	0.0123	CcSEcCtD
Verteporfin—Malnutrition—Mercaptopurine—Crohn's disease	0.0123	0.0123	CcSEcCtD
Verteporfin—Atrial fibrillation—Mesalazine—Crohn's disease	0.0117	0.0117	CcSEcCtD
Verteporfin—Dermatitis bullous—Mesalazine—Crohn's disease	0.0116	0.0116	CcSEcCtD
Verteporfin—Anaemia—Mercaptopurine—Crohn's disease	0.0114	0.0114	CcSEcCtD
Verteporfin—Osteoarthritis—Mesalazine—Crohn's disease	0.0111	0.0111	CcSEcCtD
Verteporfin—Arthralgia—Mercaptopurine—Crohn's disease	0.0105	0.0105	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.0104	0.0104	CcSEcCtD
Verteporfin—Blood creatinine increased—Mesalazine—Crohn's disease	0.0104	0.0104	CcSEcCtD
Verteporfin—Liver function test abnormal—Mesalazine—Crohn's disease	0.0102	0.0102	CcSEcCtD
Verteporfin—Oedema—Mercaptopurine—Crohn's disease	0.01	0.01	CcSEcCtD
Verteporfin—Skin disorder—Mercaptopurine—Crohn's disease	0.00976	0.00976	CcSEcCtD
Verteporfin—Influenza—Mesalazine—Crohn's disease	0.00959	0.00959	CcSEcCtD
Verteporfin—Pneumonia—Azathioprine—Crohn's disease	0.00944	0.00944	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00915	0.00915	CcSEcCtD
Verteporfin—Arthropathy—Prednisone—Crohn's disease	0.00889	0.00889	CcSEcCtD
Verteporfin—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00875	0.00875	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00867	0.00867	CcSEcCtD
Verteporfin—Pneumonia—Mesalazine—Crohn's disease	0.0086	0.0086	CcSEcCtD
Verteporfin—Hypercholesterolaemia—Prednisone—Crohn's disease	0.00855	0.00855	CcSEcCtD
Verteporfin—Cataract—Prednisone—Crohn's disease	0.0085	0.0085	CcSEcCtD
Verteporfin—Haemoglobin—Azathioprine—Crohn's disease	0.00847	0.00847	CcSEcCtD
Verteporfin—Haemorrhage—Azathioprine—Crohn's disease	0.00843	0.00843	CcSEcCtD
Verteporfin—Conjunctivitis—Mesalazine—Crohn's disease	0.00831	0.00831	CcSEcCtD
Verteporfin—Sweating—Mesalazine—Crohn's disease	0.0082	0.0082	CcSEcCtD
Verteporfin—Body temperature increased—Mercaptopurine—Crohn's disease	0.00794	0.00794	CcSEcCtD
Verteporfin—Haemoglobin—Mesalazine—Crohn's disease	0.00771	0.00771	CcSEcCtD
Verteporfin—Haemorrhage—Mesalazine—Crohn's disease	0.00768	0.00768	CcSEcCtD
Verteporfin—Pharyngitis—Mesalazine—Crohn's disease	0.00762	0.00762	CcSEcCtD
Verteporfin—Immune system disorder—Azathioprine—Crohn's disease	0.00761	0.00761	CcSEcCtD
Verteporfin—Hypersensitivity—Mercaptopurine—Crohn's disease	0.0074	0.0074	CcSEcCtD
Verteporfin—Eye disorder—Mesalazine—Crohn's disease	0.00717	0.00717	CcSEcCtD
Verteporfin—Cardiac disorder—Mesalazine—Crohn's disease	0.00712	0.00712	CcSEcCtD
Verteporfin—Angiopathy—Mesalazine—Crohn's disease	0.00696	0.00696	CcSEcCtD
Verteporfin—Immune system disorder—Mesalazine—Crohn's disease	0.00693	0.00693	CcSEcCtD
Verteporfin—Ill-defined disorder—Azathioprine—Crohn's disease	0.00681	0.00681	CcSEcCtD
Verteporfin—Anaemia—Azathioprine—Crohn's disease	0.00678	0.00678	CcSEcCtD
Verteporfin—Malaise—Azathioprine—Crohn's disease	0.00661	0.00661	CcSEcCtD
Verteporfin—Back pain—Mesalazine—Crohn's disease	0.00646	0.00646	CcSEcCtD
Verteporfin—Rash—Mercaptopurine—Crohn's disease	0.00634	0.00634	CcSEcCtD
Verteporfin—Dermatitis—Mercaptopurine—Crohn's disease	0.00633	0.00633	CcSEcCtD
Verteporfin—Vision blurred—Mesalazine—Crohn's disease	0.0063	0.0063	CcSEcCtD
Verteporfin—Arthralgia—Azathioprine—Crohn's disease	0.00624	0.00624	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.0062	0.0062	CcSEcCtD
Verteporfin—Ill-defined disorder—Mesalazine—Crohn's disease	0.0062	0.0062	CcSEcCtD
Verteporfin—Anaemia—Mesalazine—Crohn's disease	0.00618	0.00618	CcSEcCtD
Verteporfin—Discomfort—Azathioprine—Crohn's disease	0.00617	0.00617	CcSEcCtD
Verteporfin—Malaise—Mesalazine—Crohn's disease	0.00603	0.00603	CcSEcCtD
Verteporfin—Vertigo—Mesalazine—Crohn's disease	0.006	0.006	CcSEcCtD
Verteporfin—Syncope—Mesalazine—Crohn's disease	0.00599	0.00599	CcSEcCtD
Verteporfin—Nausea—Mercaptopurine—Crohn's disease	0.00597	0.00597	CcSEcCtD
Verteporfin—Loss of consciousness—Mesalazine—Crohn's disease	0.00587	0.00587	CcSEcCtD
Verteporfin—Osteoarthritis—Prednisone—Crohn's disease	0.00587	0.00587	CcSEcCtD
Verteporfin—Cough—Mesalazine—Crohn's disease	0.00583	0.00583	CcSEcCtD
Verteporfin—Skin disorder—Azathioprine—Crohn's disease	0.00581	0.00581	CcSEcCtD
Verteporfin—Hypertension—Mesalazine—Crohn's disease	0.00577	0.00577	CcSEcCtD
Verteporfin—Chest pain—Mesalazine—Crohn's disease	0.00569	0.00569	CcSEcCtD
Verteporfin—Arthralgia—Mesalazine—Crohn's disease	0.00569	0.00569	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00565	0.00565	CcSEcCtD
Verteporfin—Discomfort—Mesalazine—Crohn's disease	0.00562	0.00562	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00545	0.00545	CcSEcCtD
Verteporfin—Oedema—Mesalazine—Crohn's disease	0.00545	0.00545	CcSEcCtD
Verteporfin—Shock—Mesalazine—Crohn's disease	0.00536	0.00536	CcSEcCtD
Verteporfin—Nervous system disorder—Mesalazine—Crohn's disease	0.00535	0.00535	CcSEcCtD
Verteporfin—Skin disorder—Mesalazine—Crohn's disease	0.0053	0.0053	CcSEcCtD
Verteporfin—Hyperhidrosis—Mesalazine—Crohn's disease	0.00527	0.00527	CcSEcCtD
Verteporfin—Muscular weakness—Prednisone—Crohn's disease	0.00518	0.00518	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00517	0.00517	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00497	0.00497	CcSEcCtD
Verteporfin—Feeling abnormal—Azathioprine—Crohn's disease	0.00493	0.00493	CcSEcCtD
Verteporfin—Dyspnoea—Mesalazine—Crohn's disease	0.00486	0.00486	CcSEcCtD
Verteporfin—Body temperature increased—Azathioprine—Crohn's disease	0.00473	0.00473	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00471	0.00471	CcSEcCtD
Verteporfin—Constipation—Mesalazine—Crohn's disease	0.00466	0.00466	CcSEcCtD
Verteporfin—Pain—Mesalazine—Crohn's disease	0.00466	0.00466	CcSEcCtD
Verteporfin—Feeling abnormal—Mesalazine—Crohn's disease	0.00449	0.00449	CcSEcCtD
Verteporfin—Acute coronary syndrome—Prednisone—Crohn's disease	0.00446	0.00446	CcSEcCtD
Verteporfin—Myocardial infarction—Prednisone—Crohn's disease	0.00443	0.00443	CcSEcCtD
Verteporfin—Hypersensitivity—Azathioprine—Crohn's disease	0.00441	0.00441	CcSEcCtD
Verteporfin—Urticaria—Mesalazine—Crohn's disease	0.00433	0.00433	CcSEcCtD
Verteporfin—Body temperature increased—Mesalazine—Crohn's disease	0.00431	0.00431	CcSEcCtD
Verteporfin—Haemoglobin—Prednisone—Crohn's disease	0.00408	0.00408	CcSEcCtD
Verteporfin—Haemorrhage—Prednisone—Crohn's disease	0.00406	0.00406	CcSEcCtD
Verteporfin—Hypersensitivity—Mesalazine—Crohn's disease	0.00402	0.00402	CcSEcCtD
Verteporfin—Dizziness—Azathioprine—Crohn's disease	0.00396	0.00396	CcSEcCtD
Verteporfin—Asthenia—Mesalazine—Crohn's disease	0.00391	0.00391	CcSEcCtD
Verteporfin—Pruritus—Mesalazine—Crohn's disease	0.00386	0.00386	CcSEcCtD
Verteporfin—Eye disorder—Prednisone—Crohn's disease	0.0038	0.0038	CcSEcCtD
Verteporfin—Rash—Azathioprine—Crohn's disease	0.00377	0.00377	CcSEcCtD
Verteporfin—Dermatitis—Azathioprine—Crohn's disease	0.00377	0.00377	CcSEcCtD
Verteporfin—Flushing—Prednisone—Crohn's disease	0.00377	0.00377	CcSEcCtD
Verteporfin—Headache—Azathioprine—Crohn's disease	0.00375	0.00375	CcSEcCtD
Verteporfin—Angiopathy—Prednisone—Crohn's disease	0.00368	0.00368	CcSEcCtD
Verteporfin—Immune system disorder—Prednisone—Crohn's disease	0.00367	0.00367	CcSEcCtD
Verteporfin—Dizziness—Mesalazine—Crohn's disease	0.00361	0.00361	CcSEcCtD
Verteporfin—Nausea—Azathioprine—Crohn's disease	0.00356	0.00356	CcSEcCtD
Verteporfin—Malnutrition—Prednisone—Crohn's disease	0.00354	0.00354	CcSEcCtD
Verteporfin—Rash—Mesalazine—Crohn's disease	0.00344	0.00344	CcSEcCtD
Verteporfin—Dermatitis—Mesalazine—Crohn's disease	0.00344	0.00344	CcSEcCtD
Verteporfin—Headache—Mesalazine—Crohn's disease	0.00342	0.00342	CcSEcCtD
Verteporfin—Vision blurred—Prednisone—Crohn's disease	0.00333	0.00333	CcSEcCtD
Verteporfin—Ill-defined disorder—Prednisone—Crohn's disease	0.00328	0.00328	CcSEcCtD
Verteporfin—Anaemia—Prednisone—Crohn's disease	0.00327	0.00327	CcSEcCtD
Verteporfin—Nausea—Mesalazine—Crohn's disease	0.00324	0.00324	CcSEcCtD
Verteporfin—Malaise—Prednisone—Crohn's disease	0.00319	0.00319	CcSEcCtD
Verteporfin—Vertigo—Prednisone—Crohn's disease	0.00318	0.00318	CcSEcCtD
Verteporfin—Syncope—Prednisone—Crohn's disease	0.00317	0.00317	CcSEcCtD
Verteporfin—Loss of consciousness—Prednisone—Crohn's disease	0.00311	0.00311	CcSEcCtD
Verteporfin—Hypertension—Prednisone—Crohn's disease	0.00305	0.00305	CcSEcCtD
Verteporfin—Arthralgia—Prednisone—Crohn's disease	0.00301	0.00301	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00299	0.00299	CcSEcCtD
Verteporfin—Discomfort—Prednisone—Crohn's disease	0.00297	0.00297	CcSEcCtD
Verteporfin—Oedema—Prednisone—Crohn's disease	0.00289	0.00289	CcSEcCtD
Verteporfin—Shock—Prednisone—Crohn's disease	0.00284	0.00284	CcSEcCtD
Verteporfin—Nervous system disorder—Prednisone—Crohn's disease	0.00283	0.00283	CcSEcCtD
Verteporfin—Skin disorder—Prednisone—Crohn's disease	0.0028	0.0028	CcSEcCtD
Verteporfin—Hyperhidrosis—Prednisone—Crohn's disease	0.00279	0.00279	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.00263	0.00263	CcSEcCtD
Verteporfin—Constipation—Prednisone—Crohn's disease	0.00247	0.00247	CcSEcCtD
Verteporfin—Feeling abnormal—Prednisone—Crohn's disease	0.00238	0.00238	CcSEcCtD
Verteporfin—Urticaria—Prednisone—Crohn's disease	0.00229	0.00229	CcSEcCtD
Verteporfin—Body temperature increased—Prednisone—Crohn's disease	0.00228	0.00228	CcSEcCtD
Verteporfin—Hypersensitivity—Prednisone—Crohn's disease	0.00213	0.00213	CcSEcCtD
Verteporfin—Asthenia—Prednisone—Crohn's disease	0.00207	0.00207	CcSEcCtD
Verteporfin—Pruritus—Prednisone—Crohn's disease	0.00204	0.00204	CcSEcCtD
Verteporfin—Dizziness—Prednisone—Crohn's disease	0.00191	0.00191	CcSEcCtD
Verteporfin—Rash—Prednisone—Crohn's disease	0.00182	0.00182	CcSEcCtD
Verteporfin—Dermatitis—Prednisone—Crohn's disease	0.00182	0.00182	CcSEcCtD
Verteporfin—Headache—Prednisone—Crohn's disease	0.00181	0.00181	CcSEcCtD
Verteporfin—Nausea—Prednisone—Crohn's disease	0.00171	0.00171	CcSEcCtD
